OC3. Abstract Title: Enhanced VTE Risk Stratification in Ambulatory Patients with Cancer

Ambulatory cancer patients initiating chemotherapy are at increased risk of venous thromboembolism (VTE). The Khorana score (0  = low, 1-2 = intermediate, 3-6 = high) helps clinicians to stratify these patients according to their underlying risk of VTE. The CATS score, which incorporates additional points for elevated biomarkers (d-dimer, p-selectin), may enhance VTE risk stratification by adding up to two addit ional points to the Khorana score. We sought to evaluate the incidence of VTE in patients with a Khorana score of ≥ 2 and elevated biomarkers.

Source: Thrombosis Research - September 30, 2019 Category: Hematology Authors: J. Shaw, R. Mallick, M. Carrier, A. Ilich, N. Key, P. Wells Source Type: research